Works by Ozasa, Atsushi

Results: 10
    1

    Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 4, p. 311, doi. 10.1159/000541455
    By:
    • Kato, Daisuke;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Hayashi, Katsumi;
    • Kusakabe, Atsunori;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Mizoshita, Tsutomu;
    • Kimura, Yoshihide;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi
    Publication type:
    Article
    2

    Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study.

    Published in:
    Oncology, 2024, v. 102, n. 8, p. 676, doi. 10.1159/000536367
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    3
    4
    5

    Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan

    Published in:
    Hepatology Research, 2006, v. 36, n. 2, p. 107, doi. 10.1016/j.hepres.2006.06.001
    By:
    • Sugauchi, Fuminaka;
    • Orito, Etsuro;
    • Ohno, Tomoyoshi;
    • Tanaka, Yasuhito;
    • Ozasa, Atsushi;
    • Kang, Jong-Hon;
    • Toyoda, Joji;
    • Kuramitsu, Tomoyuki;
    • Suzuki, Kazuyuki;
    • Tanaka, Eiji;
    • Akahane, Yoshihiro;
    • Ichida, Takafumi;
    • Izumi, Namiki;
    • Inoue, Kazuaki;
    • Hoshino, Hiromi;
    • Iino, Shiro;
    • Yotsuyanagi, Hiroshi;
    • Kakumu, Shinichi;
    • Tomita, Eiichi;
    • Okanoue, Takeshi
    Publication type:
    Article
    6
    7

    Hepatitis B virus genotype G is an extremely rare genotype in Japan

    Published in:
    Hepatology Research, 2004, v. 30, n. 4, p. 199, doi. 10.1016/j.hepres.2004.09.004
    By:
    • Kato, Hideaki;
    • Sugauchi, Fuminaka;
    • Ozasa, Atsushi;
    • Kato, Takanobu;
    • Tanaka, Yasuhito;
    • Sakugawa, Hiroshi;
    • Sata, Michio;
    • Hino, Keisuke;
    • Onji, Morikazu;
    • Okanoue, Takeshi;
    • Tanaka, Eiji;
    • Kawata, Sumio;
    • Suzuki, Kazuyuki;
    • Hige, Shuhei;
    • Ohno, Tomoyoshi;
    • Orito, Etsuro;
    • Ueda, Ryuzo;
    • Mizokami, Masashi
    Publication type:
    Article
    8

    Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2025, v. 55, n. 6, p. 883, doi. 10.1111/hepr.14189
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Sobue, Satoshi;
    • Kato, Daisuke;
    • Hayashi, Katsumi;
    • Kondo, Hiromu;
    • Anbe, Kaiki;
    • Mizoshita, Tsutomu;
    • Okayama, Kohei;
    • Okumura, Fumihiro;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Inada, Hiroki;
    • Tokunaga, Takayuki;
    • Narahara, Satoshi;
    • Kawamura, Hayato;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Kataoka, Hiromi;
    • Tanaka, Yasuhito
    Publication type:
    Article
    9

    The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

    Published in:
    Hepatology Research, 2023, v. 53, n. 6, p. 511, doi. 10.1111/hepr.13886
    By:
    • Matoya, Sho;
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Suzuki, Yuta;
    • Okumura, Fumihiro;
    • Nagura, Yoshihito;
    • Sobue, Satoshi;
    • Kuroyanagi, Keita;
    • Kusakabe, Atsunori;
    • Koguchi, Hiroki;
    • Hasegawa, Izumi;
    • Miyaki, Tomokatsu;
    • Tanaka, Yoshito;
    • Kondo, Hiromu;
    • Kimura, Yoshihide;
    • Ozasa, Atsushi;
    • Kawamura, Hayato;
    • Kuno, Kayoko;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke
    Publication type:
    Article
    10

    Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.

    Published in:
    Hepatology Research, 2023, v. 53, n. 4, p. 289, doi. 10.1111/hepr.13864
    By:
    • Suzuki, Takanori;
    • Matsuura, Kentaro;
    • Urakabe, Kenji;
    • Okumura, Fumihiro;
    • Kawamura, Hayato;
    • Sobue, Satoshi;
    • Matoya, Sho;
    • Miyaki, Tomokatsu;
    • Kimura, Yoshihide;
    • Kato, Daisuke;
    • Kusakabe, Atsunori;
    • Tanaka, Yoshito;
    • Ozasa, Atsushi;
    • Nagura, Yoshihito;
    • Fujiwara, Kei;
    • Nojiri, Shunsuke;
    • Hagiwara, Shinya;
    • Kusumoto, Shigeru;
    • Inoue, Takako;
    • Tanaka, Yasuhito
    Publication type:
    Article